Editorial: Non-pharmacological Interventions for Schizophrenia: How Much Can Be Achieved and How? by Christina Andreou & Steffen Moritz
EDITORIAL
published: 29 August 2016
doi: 10.3389/fpsyg.2016.01289
Frontiers in Psychology | www.frontiersin.org 1 August 2016 | Volume 7 | Article 1289
Edited and reviewed by:
Gianluca Castelnuovo,
Catholic University of the Sacred
Heart, Italy
*Correspondence:
Christina Andreou
christina.andreou@upkbs.ch
Specialty section:
This article was submitted to
Psychology for Clinical Settings,
a section of the journal
Frontiers in Psychology
Received: 18 February 2016
Accepted: 12 August 2016
Published: 29 August 2016
Citation:
Andreou C and Moritz S (2016)
Editorial: Non-pharmacological
Interventions for Schizophrenia: How
Much Can Be Achieved and How?
Front. Psychol. 7:1289.
doi: 10.3389/fpsyg.2016.01289
Editorial: Non-pharmacological
Interventions for Schizophrenia: How
Much Can Be Achieved and How?
Christina Andreou 1, 2* and Steffen Moritz 1
1Department of Psychiatry and Psychotherapy, University Medical Center Hamburg-Eppendorf, Hamburg, Germany,
2Center for Gender Research and Early Detection, University of Basel Psychiatric Clinics, Basel, Switzerland
Keywords: psychosis, schizophrenia, psychotherapeutic processes, metacognition, neurocognition
The Editorial on the Research Topic
Non-pharmacological Interventions for Schizophrenia: HowMuch Can Be Achieved andHow?
For the greatest part of the twentieth century, symptoms of schizophrenia such as delusional beliefs
were considered to be “non-understandable,” and attempts to explain and treat these symptoms
were predominantly influenced by biological conceptualizations (Mander and Kingdon, 2015).
However, insights from behavioral, cognitive and social research as well as societal influences
(Mueser et al., 2013; Mander and Kingdon, 2015) have contributed to an increasing appreciation
of the importance of cognitive and psychological factors in understanding and treating psychotic
symptoms. At the same time, there has been growing discontent with the outcomes achieved
through antipsychotic medication alone, especially in terms of functional recovery (Leucht et al.,
2009; Jääskeläinen et al., 2013). This, combined with the high reported rates of medication
non-adherence (Lieberman et al., 2005), has led to a major boost in the development of non-
pharmacological interventions for schizophrenia.
Despite promising results, there is still much controversy regarding the usefulness and
applicability of psychological interventions in clinical practice, and there is still little evidence
regarding their mechanisms of action. The present Research Topic addresses these issues.
Naturally, an issue dealing with psychological interventions in schizophrenia could not do
without the “heavy artillery,” cognitive behavioral therapy. CBT has been one of the first non-
pharmacological interventions to be included in treatment guidelines. However, there is still an
ongoing debate about its efficacy (McKenna and Kingdon, 2014). Two articles in the present
Research Topic contribute to this debate. Peters et al. provide evidence in favor of CBT effectiveness
under routine service delivery conditions in a large sample of patients from a challenging catchment
area—a very relevant finding for clinical purposes, since everyday clinical practice may differ from
clinical studies in many aspects (e.g., patients with comorbidities, variability in therapist availability
and/or experience). On the other hand, Mehl et al. deal with the efficacy of clinical studies on
CBT for psychosis. The results of their meta-analysis indicate that CBT has a long-lasting positive
effect on delusions compared to standard care, but that this effect might be significantly reduced
when CBT is compared to other “active” psychological treatments. However, the authors also
provide tentative evidence that theory-driven interventions according to an interventionist-causal
approach may lead to improved outcomes compared to standard CBT. Thus, treatment outcomes
may be improved using more focused interventions based on knowledge of the factors contributing
to psychotic symptoms.
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Other papers in this issue take up this latter point as well.
Three papers focus on variations of metacognitive training
(MCT), one of the first interventions to address not delusions per
se, but rather reasoning biases associated with their emergence
andmaintenance. Moritz et al. show that an online metacognitive
intervention in the context of a cognitive training program
can lead to significant changes of the most prominent biases
associated with delusions. So et al. provide evidence that an
very brief course of metacognitive training can have beneficial
effects in patients with psychosis, and that changes in belief
flexibility mediate improvement in delusions. Finally, Balzan
and Galletly report on two patients refusing antipsychotic
medication, in whom individualized metacognitive therapy
led to symptom improvement, confirming that psychological
interventions may be a viable option in this patient population
(cf. Morrison et al., 2014). An interesting aspect of all three
above studies is that they describe short, low-cost interventions
that are well suited to address problems such as limited
resources and cost considerations, which may hamper the
dissemination of psychotherapy interventions (Shafran et al.,
2009).
Two papers address the processes of improvement rather
than determinants of symptoms: Westermann et al. deal with
the therapy process and propose that a structured focus on
patient motives can improve outcomes of both psychological and
pharmacological interventions in patients with psychosis. Menon
et al. discuss factors that may affect outcome in group CBT for
psychosis and identify an important issue: Despite the wealth of
clinical efficacy studies, there is still very little evidence regarding
individual factors that may affect treatment success. The authors
acknowledge sample size limitations as a cause for this problem
and suggest possible solutions.
In reading the above articles, one could think that the
factors implicated in symptoms and their improvement act
independently and/or in an additive manner. However, the
reader should keep in mind that different factors may
dynamically interact with one another, leading to complex
associations with symptoms. In a very interesting analysis,
Hesse et al. confirm that self-concept is important for the
development of paranoid delusions, but also show that self-
concept in itself may be affected by neurocognitive deficits.
Hence, cognitive remediation training might contribute to the
stability of long-term symptom outcome, even though it is not
thought to have a direct effect on delusions (Wykes et al., 2011).
However, cognitive remediation programs themselves are being
influenced by the above dynamic interaction concept, moving
away from the simple ‘drill-and-practice’ approach: In their
opinion paper, Cella et al. summarize evidence suggesting that
a metacognitive focus, i.e., promoting awareness of cognitive
strengths and weaknesses, boosts the efficacy of cognitive
remediation by helping patients develop strategies to overcome
neurocognitive deficits. Interestingly, metacognitive awareness
itself may be affected by high self-esteem (Cella et al., 2014). This
stresses the importance of keeping account of multiple patient
characteristics during therapy, however “simple” its actual focus
may be.
Several issues remain open: Many authors in this issue
highlight the need to consider outcomes other than psychotic
symptoms such as depression or well-being. The reader is
also reminded that this Research Topic represents only a
small snapshot of a fertile research field that includes a
number of alternative approaches (to name but a few, see
Kurtz and Richardson, 2012 for social cognitive training,
Khoury et al., 2013 for mindfulness interventions, and Grácio
et al., 2016 for family interventions). The optimistic take-
home message is that, although there is still much work to be
done in terms of achieving mainstream status, psychological
interventions are not only gradually establishing themselves
as effective treatments for psychotic symptoms, but are
also furthering our understanding of how these symptoms
occur.
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